Results 111 to 120 of about 3,002 (191)

Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. [PDF]

Int J Mol Sci
Horvath G, Plesz SB, Ducza E, Varga D, Szucs E, Benyhe S, Adlan LG, Braunitzer G, Kekesi G.   +8 more
europepmc   +1 more source

Dopamine receptors and organ fibrosis. [PDF]

Biochem Biophys Rep
Liao Z, Tang X, Yang B, Yang J.
europepmc   +1 more source

Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder. [PDF]

Molecules
Jończyk J, Przybylska K, Staszewski M, Godyń J, Werner T, Stefaniak-Napieralska M, Stark H, Walczyński K, Bajda M.   +8 more
europepmc   +1 more source

Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics. [PDF]

ACS Pharmacol Transl Sci
Alkhatib M, Jakobs FM, Hanson JN, Nilson AN, Moritz AE, Li T, Faibille AB, Bourn LA, Ramdhan PA, Ricchezza J, Jordan S, Panasis D, Nguyen N, Kasarla N, Wang B, Garcia SS, Saez J, Paule J, Lee CB, Rais R, Slusher BS, Sibley DR, Li C, Keck TM, Boateng CA.   +24 more
europepmc   +1 more source

Molecular Dynamics and Electron Density Topology Reveal Ligand-Specific Interaction Patterns at the Dopamine D₂ Receptor. [PDF]

Int J Mol Sci
Padilla-Bernal G, Herrera-Zúñiga LD, Vargas R.   +2 more
europepmc   +1 more source

The Binding of the High Affinity Radioligand Fallypride to the D2-dopamine Receptor is Sensitive to Injected Mass - a PET Study in Rodents. [PDF]

Mol Imaging Biol
Tóth M, Tari L, Nag S, Qiu T, Jia Z, Häggkvist J, Mukherjee J, Varrone A, Halldin C, Farde L.   +9 more
europepmc   +1 more source

Aberrant Fear: Biological Underpinnings Relevant to Psychosis, Antipsychotic Drugs, and Psychotherapeutic Treatments, a Translational Approach. [PDF]

Int J Mol Sci
Mazza B, Vellucci L, Ciccarelli M, Iasevoli F, Vitelli R, De Simone G, Tomasetti C, Fukutomi M, Barone A, de Bartolomeis A.   +9 more
europepmc   +1 more source

A review of the neuropharmacological profile of schedule-induced polydipsia. [PDF]

J Exp Anal Behav
Lalonde R, Strazielle C.
europepmc   +1 more source

Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia. [PDF]

Am J Psychiatry
Ku SH, Stringfield SJ, Torregrossa MM, Sweet RA, Chou S.   +4 more
europepmc   +1 more source

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines. [PDF]

Front Pharmacol
Kolaczynska KE, Trachsel D, Hoener MC, Liechti ME, Luethi D.   +4 more
europepmc   +1 more source